• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过生物信息学改善新冠病毒病及其后遗症的潜力

The Potential of Ameliorating COVID-19 and Sequelae From via Bioinformatics.

作者信息

Nguyen Hien Thi, Do Van Mai, Phan Thanh Thuy, Nguyen Huynh Dung Tam

机构信息

Faculty of Public Health, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam.

Faculty of Traditional Medicine, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam.

出版信息

Bioinform Biol Insights. 2023 Jan 12;17:11779322221149622. doi: 10.1177/11779322221149622. eCollection 2023.

DOI:10.1177/11779322221149622
PMID:36654765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9841859/
Abstract

The current coronavirus disease 2019 (COVID-19) outbreak is alarmingly escalating and raises challenges in finding efficient compounds for treatment. Repurposing phytochemicals in herbs is an ideal and economical approach for screening potential herbal components against COVID-19. , also known as Chuan Xin Lian, has traditionally been used as an anti-inflammatory and antibacterial herb for centuries and has recently been classified as a promising herbal remedy for adjuvant therapy in treating respiratory diseases. This study aimed to screen Chuan Xin Lian's bioactive components and elicit the potential pharmacological mechanisms and plausible pathways for treating COVID-19 using network pharmacology combined with molecular docking. The results found terpenoid (andrographolide) and flavonoid (luteolin, quercetin, kaempferol, and wogonin) derivatives had remarkable potential against COVID-19 and sequelae owing to their high degrees in the component-target-pathway network and strong binding capacities in docking scores. In addition, the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that the PI3K-AKT signaling pathway might be the most vital molecular pathway in the pathophysiology of COVID-19 and long-term sequelae whereby therapeutic strategies can intervene.

摘要

当前的2019冠状病毒病(COVID-19)疫情正惊人地升级,在寻找有效治疗化合物方面带来了挑战。重新利用草药中的植物化学物质是筛选针对COVID-19的潜在草药成分的理想且经济的方法。穿心莲,传统上几个世纪以来一直被用作抗炎和抗菌草药,最近被归类为治疗呼吸道疾病辅助治疗的有前景的草药疗法。本研究旨在通过网络药理学结合分子对接来筛选穿心莲的生物活性成分,并阐明其治疗COVID-19的潜在药理机制和合理途径。结果发现,萜类化合物(穿心莲内酯)和黄酮类化合物(木犀草素、槲皮素、山奈酚和汉黄芩素)衍生物由于在成分-靶点-途径网络中的高度参与以及对接分数中的强结合能力,对COVID-19及其后遗症具有显著潜力。此外,京都基因与基因组百科全书(KEGG)途径分析表明,PI3K-AKT信号通路可能是COVID-19病理生理学和长期后遗症中最重要的分子途径,治疗策略可以据此进行干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/23572b732de6/10.1177_11779322221149622-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/6913ce28f3dd/10.1177_11779322221149622-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/3b21cfb4bde5/10.1177_11779322221149622-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/cc7a81980f41/10.1177_11779322221149622-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/791e1d955fdd/10.1177_11779322221149622-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/7321e547d564/10.1177_11779322221149622-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/373340cfd455/10.1177_11779322221149622-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/23572b732de6/10.1177_11779322221149622-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/6913ce28f3dd/10.1177_11779322221149622-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/3b21cfb4bde5/10.1177_11779322221149622-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/cc7a81980f41/10.1177_11779322221149622-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/791e1d955fdd/10.1177_11779322221149622-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/7321e547d564/10.1177_11779322221149622-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/373340cfd455/10.1177_11779322221149622-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c205/9841859/23572b732de6/10.1177_11779322221149622-fig7.jpg

相似文献

1
The Potential of Ameliorating COVID-19 and Sequelae From via Bioinformatics.通过生物信息学改善新冠病毒病及其后遗症的潜力
Bioinform Biol Insights. 2023 Jan 12;17:11779322221149622. doi: 10.1177/11779322221149622. eCollection 2023.
2
Andrographis paniculata (Burm.f.) Nees: Traditional uses, phytochemistry, pharmacological properties and quality control/quality assurance.穿心莲(Burm.f.) Nees:传统用途、植物化学、药理性质和质量控制/质量保证。
J Ethnopharmacol. 2021 Jul 15;275:114054. doi: 10.1016/j.jep.2021.114054. Epub 2021 Apr 6.
3
Mechanism of andrographis paniculata on lung cancer by network pharmacology and molecular docking.穿心莲治疗肺癌的作用机制:网络药理学和分子对接研究。
Technol Health Care. 2023;31(4):1407-1427. doi: 10.3233/THC-220698.
4
Network pharmacology integrated with experimental validation revealed the anti-inflammatory effects of Andrographis paniculata.网络药理学结合实验验证揭示穿心莲的抗炎作用。
Sci Rep. 2021 May 7;11(1):9752. doi: 10.1038/s41598-021-89257-6.
5
Deciphering the potential anti-COVID-19 active ingredients in (Burm. F.) Nees by combination of network pharmacology, molecular docking, and molecular dynamics.通过网络药理学、分子对接和分子动力学相结合的方法解析(缅甸)爵床(Nees)中潜在的抗COVID-19活性成分
RSC Adv. 2021 Nov 11;11(58):36511-36517. doi: 10.1039/d1ra06487h. eCollection 2021 Nov 10.
6
Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.基于网络药理学和分子对接的麻黄草治疗肾病综合征的潜在分子机制。
Biomed Res Int. 2022 Jul 5;2022:9214589. doi: 10.1155/2022/9214589. eCollection 2022.
7
Immunoprotective potential of Ayurvedic herb Kalmegh (Andrographis paniculata) against respiratory viral infections - LC-MS/MS and network pharmacology analysis.草药穿心莲(穿心莲)对呼吸道病毒感染的免疫保护潜力 - LC-MS/MS 和网络药理学分析。
Phytochem Anal. 2021 Jul;32(4):629-639. doi: 10.1002/pca.3011. Epub 2020 Nov 9.
8
Study on the mechanism of treating COVID-19 with Shenqi Wan based on network pharmacology.基于网络药理学的参芪丸治疗新型冠状病毒肺炎机制研究
Drug Dev Ind Pharm. 2021 Aug;47(8):1279-1289. doi: 10.1080/03639045.2021.1989453. Epub 2021 Oct 21.
9
Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis.基于网络药理学预测和分子对接的方法发现槐黄散治疗溃疡性结肠炎的潜在作用机制。
Drug Des Devel Ther. 2021 Jul 28;15:3255-3276. doi: 10.2147/DDDT.S319786. eCollection 2021.
10
Can network pharmacology identify the anti-virus and anti- inflammatory activities of Shuanghuanglian oral liquid used in Chinese medicine for respiratory tract infection?网络药理学能否鉴定中药双黄连口服液用于呼吸道感染的抗病毒和抗炎活性?
Eur J Integr Med. 2020 Aug;37:101139. doi: 10.1016/j.eujim.2020.101139. Epub 2020 May 26.

引用本文的文献

1
Genome-wide identification and characterization of dicer-like genes in (Burm. f.) Wall. ex Nees and their expression response to methyl jasmonate elicitation.(缅甸)毛竹中类Dicer基因的全基因组鉴定与特征分析及其对茉莉酸甲酯诱导的表达响应
3 Biotech. 2025 May;15(5):141. doi: 10.1007/s13205-025-04300-x. Epub 2025 Apr 24.
2
Antiviral Activity and Underlying Mechanism of Aqueous Extract for Treating SARS-CoV-2.治疗新型冠状病毒肺炎水提取物的抗病毒活性及潜在机制
Molecules. 2025 Jan 17;30(2):387. doi: 10.3390/molecules30020387.
3
Taiwan Chingguan Yihau may improve post-COVID-19 respiratory complications through PI3K/AKT, HIF-1, and TNF signaling pathways revealed by network pharmacology analysis.

本文引用的文献

1
Traditional Chinese medicine combined with Moxibustion in the treatment of "long-COVID": A protocol for systematic review and meta-analysis.中文医学与艾灸联合治疗“长新冠”:系统评价和荟萃分析方案。
Medicine (Baltimore). 2022 Oct 28;101(43):e31447. doi: 10.1097/MD.0000000000031447.
2
Interventions for Improving Long COVID-19 Symptomatology: A Systematic Review.改善长新冠症状的干预措施:系统评价。
Viruses. 2022 Aug 24;14(9):1863. doi: 10.3390/v14091863.
3
Application of network pharmacology in the study of the mechanism of action of traditional chinese medicine in the treatment of COVID-19.
通过网络药理学分析揭示,台湾清冠一号可能通过PI3K/AKT、HIF-1和TNF信号通路改善新冠后呼吸并发症。
Mol Divers. 2025 Jun;29(3):2305-2321. doi: 10.1007/s11030-024-10993-8. Epub 2024 Oct 9.
网络药理学在中药治疗新型冠状病毒肺炎作用机制研究中的应用
Front Pharmacol. 2022 Aug 4;13:926901. doi: 10.3389/fphar.2022.926901. eCollection 2022.
4
Therapeutic and prophylactic effect of flavonoids in post-COVID-19 therapy.COVID-19 后治疗中类黄酮的治疗和预防作用。
Phytother Res. 2022 May;36(5):2042-2060. doi: 10.1002/ptr.7436. Epub 2022 Mar 18.
5
Treatment efficacy of Lianhua Qingwen capsules for eraly-stage COVID-19.连花清瘟胶囊对COVID-19早期的治疗效果。
Am J Transl Res. 2022 Feb 15;14(2):1332-1338. eCollection 2022.
6
Pathological sequelae of long-haul COVID.长新冠的病理后遗症。
Nat Immunol. 2022 Feb;23(2):194-202. doi: 10.1038/s41590-021-01104-y. Epub 2022 Feb 1.
7
Research Progress in the Treatment of Complications and Sequelae of COVID-19.新型冠状病毒肺炎并发症及后遗症的治疗研究进展
Front Med (Lausanne). 2021 Dec 2;8:757605. doi: 10.3389/fmed.2021.757605. eCollection 2021.
8
Antiviral Activities of Andrographolide and Its Derivatives: Mechanism of Action and Delivery System.穿心莲内酯及其衍生物的抗病毒活性:作用机制与递送系统
Pharmaceuticals (Basel). 2021 Oct 28;14(11):1102. doi: 10.3390/ph14111102.
9
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.新型冠状病毒肺炎涉及的分子途径及基于途径的潜在治疗靶点。
Biomed Pharmacother. 2022 Jan;145:112420. doi: 10.1016/j.biopha.2021.112420. Epub 2021 Nov 12.
10
A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm.一种计算方法鉴定穿心莲内酯可作为抑制 COVID-19 诱导的细胞因子风暴的潜在药物。
Front Immunol. 2021 Jun 24;12:648250. doi: 10.3389/fimmu.2021.648250. eCollection 2021.